Orion Stock - Weekly review and pharma sector comparison
19.06.2026 - 18:04:30 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 18:00 EET. Details in the imprint.
Orion (FI0009014377) is ending the week without a new market-moving announcement. With no fresh filings or ad-hoc releases on Friday from the Finnish pharmaceutical group’s investor relations page, the focus shifts to how the stock stacks up against its European pharma peers. Orion investor relations overview
All news and key data on Orion stock
Stay on top of Orion’s latest disclosures, analyst reactions and price data with our curated topic page and the company’s own investor information.
What this quiet week shows
Orion’s investor relations site lists no new company releases or financial reports dated this Friday, underscoring a comparatively calm news backdrop for the stock after earlier spring updates. Latest Orion releases
In the absence of fresh headlines, traders are left digesting prior information on Orion’s pipeline, recent financial performance and dividend profile, while monitoring broader sector moves and macro news for indirect effects on healthcare valuations.
How Orion compares to peers
Against European pharma majors such as Novo Nordisk, Roche and Novartis, Orion remains a smaller, more specialized player focused on prescription medicines, veterinary products and active pharmaceutical ingredients.
The company is nevertheless followed by international investors via its Helsinki listing and its role in Nordic equity indices, placing it firmly within the wider European healthcare benchmark landscape. Orion listing information on Nasdaq Helsinki
How the company makes money
Orion generates revenue primarily from human prescription medicines, specialty products and animal health treatments, complemented by manufacturing and selling active pharmaceutical ingredients to other drugmakers under longer-term contracts.
Where the stock trades today
The shares of Orion (FI0009014377) trade on Nasdaq Helsinki at EUR 28.50 as of 06/19/2026, 17:45 EET.
Key facts on Orion stock
- Company: Orion Oyj
- ISIN: FI0009014377
- WKN: 870199
- Ticker: ORNBV
- Venue: Nasdaq Helsinki
- Price (as of 06/19/2026, 17:45 EET): 28.50 EUR
- Market cap: 4,600,000,000 EUR (as of 06/19/2026)
- Sector / Industry: Health Care - Pharmaceuticals
- Index membership: OMX Helsinki 25
- Next earnings date: 07/18/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
